Kohlberg Kravis Roberts & Co »

Synaptics shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Synaptics shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Synaptics

Tip: Access up to 7 years of quarterly data

All positions including Synaptics held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Synaptics by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $332k 320k 1.04
2025-12-31 $339k 320k 1.06

More positions owned by Kohlberg Kravis Roberts & Co

Brightspring Health Svcs (BTSG)
Henry Schein (HSIC)
Bridgebio Pharma (BBIO)
Crescent Energy Company Cl A Com (CRGY)
Niq Global Intelligence Ordinary Shares (NIQ)
Brightview Holdings (BV)
Kkr Real Estate Finance Trust (KREF)
Paramount Skydance Corp Com Cl B (PSKY)
American Wtr Cap Corp Note 3.625% 6/1 (Principal)
Block Note 5/0 (Principal)
Oxford Lane Cap Corp (OXLC)
Bausch Health Companies (BHC)
Northern Oil & Gas Note 3.625% 4/1 (Principal)
Immunocore Hldgs Note 2.500% 2/0 (Principal)
Sabre Glbl Note 7.320% 8/0 (Principal)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Synaptics

Ing Investment Management
Linden Advisors
Wellesley Investment Advisors
Silverback Asset Management
Thrivent Financial for Lutherans
MacKay Shields
Davidson Kempner Capital Management
Oaktree Capital Management
Ameriprise Financial
State Street Corporation
BlackRock
Calamos Advisors
Shenkman Capital Management
Morgan Stanley
FMR

View all funds holding Synaptics